Steve Abbott- Prostate Cancer Awareness Advocate- Being the best version of himself

STEVEN M. (“STEVE”) ABBOTT

EXECUTIVE DIRECTOR – THE CINCINNATI CANCER FOUNDATION, INC. (“CCF”)

Steve’s career has been quite varied, encompassing finance, accounting, treasury operations, capital markets, business development, marketing and sales, across a variety of industries and ownership structures. This has put him in a uniquely good position to lead CCF, which is the funding engine for Cincinnati Cancer Advisors (“CCA”), a mission-driven oncology practice providing platinum-level care,
free of charge to more than 400 cancer patients in the Greater Cincinnati area each year. Steve is responsible for all of CCF’s functional areas with the exception of clinical practice and operations.

Steve is the founder of CCA’s inventive “Medical Minute” podcast series, which is designed to improve patient outcomes by simplifying the information that is given to patients as part of their treatment decision-making process. Medical Minute’s first podcast was released in November 2021 and though growth has been modest, there are now more than 750 subscribers to the Medical Minute YouTube  channel and viewer response has been very favorable to date.

He is also the founder of the Cincinnati Cancer Consortium (“CCC”), a collaboration of some of Cincinnati’s most revered cancer care organizations. The goals of CCC are to promote awareness of each participating organization’s unique, patient-focused programs, and to optimize each organization’s financial health through resource sharing and fundraising collaboration.

Steve’s past volunteer efforts have benefited the University of Cincinnati (UC) Cancer Center, UC Health, the American Cancer Society, ZERO Prostate Cancer, and the V Foundation, among others. He and his wife Diana – also a cancer survivor – have spoken on cancer-related topics at a variety of oncology conferences throughout the Midwest region (all honoraria received from these speaking engagements have been donated to charity).

A ten-year prostate cancer survivor, Steve serves as a consumer reviewer for the U.S. Department of Defense’s Prostate Cancer Research Program, a program that has funded some of the most groundbreaking drugs for advanced prostate cancer in the past quarter-century. Steve and his fellow volunteer lobbyists have not only been successful in keeping funding alive for this vital, life-saving research program, but their collective efforts have resulted in $30 million in additional funding over the last six-year period. Steve is also a member of the Prostate Cancer Lab, an organization of advanced
prostate cancer patients focused on a better understanding of applying next generation sequencing techniques to improve for these patients, as well as all prostate cancer patients.